vs

Side-by-side financial comparison of Seer, Inc. (SEER) and 10x Genomics, Inc. (TXG). Click either name above to swap in a different company.

Seer, Inc. is an American biotechnology company headquartered in Redwood City, California. Established in 2017, the company develops technologies for proteomics research.

10x Genomics, Inc. is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. It was founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SEER
SEER
TXG
TXG
Q4 25
$4.2M
Q3 25
$4.1M
Q2 25
$4.1M
Q1 25
$4.2M
Q4 24
$4.0M
Q3 24
$4.0M
Q2 24
$3.1M
Q1 24
$3.1M
Net Profit
SEER
SEER
TXG
TXG
Q4 25
$-16.0M
Q3 25
$-18.2M
Q2 25
$-19.4M
Q1 25
$-19.9M
Q4 24
$-21.7M
Q3 24
$-21.3M
Q2 24
$-22.9M
Q1 24
$-20.7M
Gross Margin
SEER
SEER
TXG
TXG
Q4 25
52.0%
Q3 25
51.2%
Q2 25
52.1%
Q1 25
49.0%
Q4 24
50.6%
Q3 24
48.1%
Q2 24
56.3%
Q1 24
44.4%
Operating Margin
SEER
SEER
TXG
TXG
Q4 25
-413.8%
Q3 25
-469.4%
Q2 25
-506.8%
Q1 25
-493.0%
Q4 24
-587.2%
Q3 24
-603.3%
Q2 24
-882.0%
Q1 24
-821.7%
Net Margin
SEER
SEER
TXG
TXG
Q4 25
-380.7%
Q3 25
-442.5%
Q2 25
-479.5%
Q1 25
-474.4%
Q4 24
-543.6%
Q3 24
-529.0%
Q2 24
-743.8%
Q1 24
-674.5%
EPS (diluted)
SEER
SEER
TXG
TXG
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$-0.35
Q2 24
$-0.35
Q1 24
$-0.32

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons